Statins are among the most prescribed drugs in the United States. Yet a recent study suggests that only 35% of people who could benefit from these cholesterol-lowering drugs are taking them. The study, published in 2023 in the Annals of Internal Medicine, also found that most adults with the highest risk for a first heart attack or stroke aren’t getting statins.
“Statins are a very effective treatment for reducing high cholesterol and risk for heart attack and stroke,” says Mass General Brigham cardiologist Paul Ridker, MD, MPH. Dr. Ridker cares for patients at Brigham and Women’s Hospital.
Cholesterol is a necessary fat that the body needs to function. The body produces cholesterol in the liver. From there it travels in the bloodstream. You also get dietary cholesterol from eating certain foods, mainly animal products such as meat and dairy and some tropical oils like coconut oil.
“The most important component of cholesterol to know is low-density lipoprotein (LDL),” says Dr. Ridker. LDL is commonly called “bad” cholesterol because it can cause fatty deposits (plaque) to build up in the arteries.
Cholesterol also contains high-density lipoprotein (HDL) or “good” cholesterol, which removes excess LDL from the body. When there’s too much LDL and not enough HDL, plaque can block the flow of blood or cause blood clots, leading to heart attack and stroke.
If you’ve never had a heart attack or stroke, lowering your LDL cholesterol helps reduce your risk of having one. If you already have cardiovascular disease, it decreases your risk of having another event. Statins help prevent heart disease and stroke by slowing LDL production in the liver to treat high cholesterol (hyperlipidemia) and reduce plaque buildup.
“Controlling your cholesterol with a statin can cut your risk of heart attack and stroke by 30%,” says Dr. Ridker, referring to previous research in the New England Journal of Medicine. “It’s like putting your seatbelt on when you get in a car. We’re trying to lower your risk of a bad outcome that’s otherwise avoidable.”
The American Heart Association (AHA) suggests that anyone with a history of atherosclerotic disease (plaque buildup) should consider statin therapy with an aim of getting their LDL level below 70 milligrams per deciliter (mg/dL).
For people who don’t have a history of atherosclerotic disease but who are at high risk, the AHA strongly suggests statin therapy when LDL is greater than 190 mg/dL.
Dr. Ridker notes that statin therapy should also be considered for people with lower LDL levels if they have diabetes, high estimates of lifetime risk, or a strong family history of heart disease at a young age. “For these ‘primary prevention’ patients, the goal of statin therapy is to get LDL lower than 100 mg/dL,” he says.
Some factors that can put people without heart disease symptoms at higher risk are:
Coronary calcium levels as detected by a coronary artery calcium (CAC) scan, which can indicate coronary artery disease
Diabetes
High levels of lipoprotein(a) (greater than 50 mg/dL), a type of LDL
Inflammation, indicated by C-reactive protein (a protein made by the liver) greater than 2 mg/L
Peripheral arterial disease
Strong family history of heart disease at a young age
Because you can have high LDL cholesterol and not have symptoms, it’s important to have your cholesterol checked regularly. “For the vast majority of patients, the only way to detect this is by measuring cholesterol with a simple blood test, which is typically done as a routine part of your annual checkup,” says Dr. Ridker.